Rare diseases
Investigational molecules
Locations
Back to Poland3 clinical trials in Pleszew, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)PolandPolandPolandThe busiest research cities in the country
What the registry says about research in the country
Ongoing clinical trials focusing on advanced treatment approaches for hormone receptor-positive (HR+) and HER2-negative breast cancer. The research evaluates combination therapies to improve progression-free survival in patients who have experienced disease progression after initial treatment.
Studies incorporate novel therapeutic combinations with established treatments like fulvestrant to enhance treatment outcomes.
Innovative research examining the effectiveness of immunotherapy combinations in treating triple-negative breast cancer (TNBC). These trials evaluate various therapeutic approaches for patients with locally recurrent inoperable or metastatic disease.
The research compares different treatment combinations including olaparib and pembrolizumab against standard chemotherapy regimens.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
